Haloperidol decanoate in chronic schizophrenia: A study of 12 months with plasma levels

@article{Altamura1990HaloperidolDI,
  title={Haloperidol decanoate in chronic schizophrenia: A study of 12 months with plasma levels},
  author={Carlo Alfredo Altamura and F. Colacurcio and Massimo C. Kauri and Anna R. Moro and Fedele De Novellis},
  journal={Progress in Neuro-Psychopharmacology and Biological Psychiatry},
  year={1990},
  volume={14},
  pages={25-35}
}
1. Clinical activity, extrapyramidal side-effects were evaluated in 22 schizophrenic out patients diagnosed according to DSM III and treated with haloperidol decanoate (50-300 mg i.m. monthly dose) for 12 months. 2. BPRS total scores did not show significant fluctuations showing a clinical stability of the patient population. 3. Patients with a duration of illness greater than 10 yrs (Group 2) showed significant (p less than 0.01) higher EPSE total scores compared to those with a duration of… CONTINUE READING

From This Paper

Topics from this paper.

References

Publications referenced by this paper.
Showing 1-10 of 21 references

PERCUDANI,M. and VAMPINI, C.(1989) Residual neuroleptic induced parkinsonian symptoms in schizophrenia (a naturalistic study with orphenadrine)

A. C. ALTAMURA, M. C. MAURI, F. DE NOVELLIS
Pharmacopsychiatry • 1989

Similar Papers

Loading similar papers…